3min chapter

Open to Debate cover image

Is the FDA Too Cautious?

Open to Debate

CHAPTER

The Future of Drug Regulation

"I'm arguing for that balance to be in a different place," he says. "You can't talk about efficacy or the fact it works without talking about personalized medicine" The question is, what could the FDA become as the world leader in regulatory science? Do you want to respond? I have a question for you, but I want to do a genomics.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode